202 related articles for article (PubMed ID: 29493809)
1. Use of attention-deficit/hyperactivity disorder medication among older adults in Denmark.
Ormhøj SS; Pottegård A; Gasse C; Rasmussen L
Br J Clin Pharmacol; 2018 Jul; 84(7):1505-1513. PubMed ID: 29493809
[TBL] [Abstract][Full Text] [Related]
2. The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective.
Pottegård A; Bjerregaard BK; Glintborg D; Kortegaard LS; Hallas J; Moreno SI
Eur J Clin Pharmacol; 2013 Mar; 69(3):589-98. PubMed ID: 22811260
[TBL] [Abstract][Full Text] [Related]
3. Utilization of Stimulants and Atomoxetine for Attention-Deficit/Hyperactivity Disorder among 5.4 Million Children Using Population-Based Longitudinal Data.
Furu K; Karlstad Ø; Zoega H; Martikainen JE; Bahmanyar S; Kieler H; Pottegård A
Basic Clin Pharmacol Toxicol; 2017 Apr; 120(4):373-379. PubMed ID: 27911044
[TBL] [Abstract][Full Text] [Related]
4. [Supervised off-label prescribing of methylphenidate in adult ADHD].
Carton L; Dondaine T; Deheul S; Marquié C; Brigadeau F; Amad A; Devos D; Danel T; Bordet R; Cottencin O; Gautier S; Ménard O
Encephale; 2019 Feb; 45(1):74-81. PubMed ID: 30122296
[TBL] [Abstract][Full Text] [Related]
5. The use of medication against attention deficit hyperactivity disorder in Denmark: a drug use study from a national perspective.
Pottegård A; Bjerregaard BK; Glintborg D; Hallas J; Moreno SI
Eur J Clin Pharmacol; 2012 Oct; 68(10):1443-50. PubMed ID: 22434389
[TBL] [Abstract][Full Text] [Related]
6. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
Wong IC; Asherson P; Bilbow A; Clifford S; Coghill D; DeSoysa R; Hollis C; McCarthy S; Murray M; Planner C; Potts L; Sayal K; Taylor E
Health Technol Assess; 2009 Oct; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of and Factors Associated With Long-term Concurrent Use of Stimulants and Opioids Among Adults With Attention-Deficit/Hyperactivity Disorder.
Wei YJ; Zhu Y; Liu W; Bussing R; Winterstein AG
JAMA Netw Open; 2018 Aug; 1(4):e181152. PubMed ID: 30646105
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of prescribed attention-deficit hyperactivity disorder medications and diagnosis among Canadian preschoolers and school-age children: 1994-2007.
Brault MC; Lacourse É
Can J Psychiatry; 2012 Feb; 57(2):93-101. PubMed ID: 22340149
[TBL] [Abstract][Full Text] [Related]
9. Latest trends in ADHD drug prescribing patterns in children in the UK: prevalence, incidence and persistence.
Beau-Lejdstrom R; Douglas I; Evans SJ; Smeeth L
BMJ Open; 2016 Jun; 6(6):e010508. PubMed ID: 27297009
[TBL] [Abstract][Full Text] [Related]
10. Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases.
Raman SR; Man KKC; Bahmanyar S; Berard A; Bilder S; Boukhris T; Bushnell G; Crystal S; Furu K; KaoYang YH; Karlstad Ø; Kieler H; Kubota K; Lai EC; Martikainen JE; Maura G; Moore N; Montero D; Nakamura H; Neumann A; Pate V; Pottegård A; Pratt NL; Roughead EE; Macias Saint-Gerons D; Stürmer T; Su CC; Zoega H; Sturkenbroom MCJM; Chan EW; Coghill D; Ip P; Wong ICK
Lancet Psychiatry; 2018 Oct; 5(10):824-835. PubMed ID: 30220514
[TBL] [Abstract][Full Text] [Related]
11. Children's relative age in class and use of medication for ADHD: a Danish Nationwide Study.
Pottegård A; Hallas J; Hernández-Díaz ; Zoëga H
J Child Psychol Psychiatry; 2014 Nov; 55(11):1244-50. PubMed ID: 24813478
[TBL] [Abstract][Full Text] [Related]
12. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
[TBL] [Abstract][Full Text] [Related]
13. Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Depression: A Nationwide Longitudinal Cohort Study.
Chang Z; D'Onofrio BM; Quinn PD; Lichtenstein P; Larsson H
Biol Psychiatry; 2016 Dec; 80(12):916-922. PubMed ID: 27086545
[TBL] [Abstract][Full Text] [Related]
14. Early discontinuation of attention-deficit/hyperactivity disorder drug treatment: a Danish nationwide drug utilization study.
Pottegård A; Bjerregaard BK; Kortegaard LS; Zoëga H
Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):349-53. PubMed ID: 25220739
[TBL] [Abstract][Full Text] [Related]
15. The association between medication for attention-deficit/hyperactivity disorder and cancer.
Steinhausen HC; Helenius D
J Child Adolesc Psychopharmacol; 2013 Apr; 23(3):208-13. PubMed ID: 23560601
[TBL] [Abstract][Full Text] [Related]
16. Substance use disorders in association with attention-deficit/hyperactivity disorder, co-morbid mental disorders, and medication in a nationwide sample.
Steinhausen HC; Bisgaard C
Eur Neuropsychopharmacol; 2014 Feb; 24(2):232-41. PubMed ID: 24314850
[TBL] [Abstract][Full Text] [Related]
17. Nationwide rate of attention-deficit hyperactivity disorder diagnosis and pharmacotherapy in Korea in 2008-2011.
Hong M; Kwack YS; Joung YS; Lee SI; Kim B; Sohn SH; Chung US; Yang J; Bhang SY; Hwang JW; Choi HY; Oh IH; Lee YJ; Bahn GH
Asia Pac Psychiatry; 2014 Dec; 6(4):379-85. PubMed ID: 25277653
[TBL] [Abstract][Full Text] [Related]
18. Methylphenidate in Adults with Attention Deficit Hyperactivity Disorder and Substance Use Disorders.
Simon N; Rolland B; Karila L
Curr Pharm Des; 2015; 21(23):3359-66. PubMed ID: 26088112
[TBL] [Abstract][Full Text] [Related]
19. Patient and provider characteristics related with prescribing of ADHD medication: Nationwide health insurance claims database study in Korea.
Song I; Lee MS; Lee EK; Shin JY
Asia Pac Psychiatry; 2018 Mar; 10(1):. PubMed ID: 28631372
[TBL] [Abstract][Full Text] [Related]
20. Prescriptions for ADHD medication, 2004-08.
Lillemoen PK; Kjosavik SR; Hunskår S; Ruths S
Tidsskr Nor Laegeforen; 2012 Sep; 132(16):1856-60. PubMed ID: 22986969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
